Loading...

VKTX VIKING THERAPEUTICS INC Product Launches 8-K Filing

VKNG

VKTX

VIKING THERAPEUTICS INC

(VKTX)

2024 8-K

Show Summary

Show Summary

Financial Statements

Supply Agreement

Clinical Trial Results

Q3 Financial Results

Earnings Reports

Results Announcement

Annual Meeting Approval

Earnings Reports

Clinical Trial Results

Underwriting Agreement for ...

Earnings Reports

Earnings Reports

Earnings Reports

Annual Meeting of Stockholders

Bylaw Amendment

Earnings Reports

Underwriting Agreement for ...

Clinical Study Initiation

Clinical Trial Results

Earnings Report

External Links:

Viking Therapeutics announced results from its Phase 2 VENTURE trial of VK2735 in patients with obesity.

AI Assistant

VIKING THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.